SLS (SELLAS Life Sciences Group) OCF Yield %: -1.56 (As of Jun. 25, 2026)


SLS SELLAS Life Sciences Group Inc SLS
25 GF Score
Price $9.17
! 1 Warning Sign
View Full Analysis

What is SELLAS Life Sciences Group OCF Yield %?

SELLAS Life Sciences Group SLS +0.05% 25 OCF Yield % is -1.56 as of Jun. 25, 2026. GuruFocus rates SLS with a GF Score™ of 25/100. The stock has 1 warning sign investors should review. Among 1,419 Biotechnology companies, SELLAS Life Sciences Group ranks better than 72.8% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, SELLAS Life Sciences Group's Trailing 12-Month Cash Flow from Operations is $-28.17 Mil, and Market Cap is $1,803.12 Mil. Therefore, SELLAS Life Sciences Group's OCF Yield % for today is -1.56%.

The historical rank and industry rank for SELLAS Life Sciences Group's OCF Yield % or its related term are showing as below:

SLS' s OCF Yield % Range Over the Past 10 Years
Min: -226.38   Med: -59.97   Max: -1.56
Current: -1.56

During the past 13 years, the highest OCF Yield % of SELLAS Life Sciences Group was -1.56%. The lowest was -226.38%. And the median was -59.97%.

SLS's OCF Yield % is ranked better than
72.8% of 1419 companies
in the Biotechnology industry
Industry Median: -8.46 vs SLS: -1.56

SELLAS Life Sciences Group's OCF Margin % for the quarter that ended in Mar. 2026 was %.

SELLAS Life Sciences Group OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

SELLAS Life Sciences Group OCF Yield % Related Terms

SELLAS Life Sciences Group OCF Yield % Historical Data

* Premium members only.

The historical data trend for SELLAS Life Sciences Group's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SELLAS Life Sciences Group OCF Yield % Chart

SELLAS Life Sciences Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -29.60 -48.03 -92.22 -46.01 -4.92

SELLAS Life Sciences Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -36.96 -13.34 -14.04 -3.41 -4.61

SLS vs SNDX, CAPR, AGIO: OCF Yield % Comparison

For the Biotechnology subindustry, SELLAS Life Sciences Group's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SELLAS Life Sciences Group OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SELLAS Life Sciences Group's OCF Yield % distribution charts can be found below:

* The bar in red indicates where SELLAS Life Sciences Group's OCF Yield % falls into.


SLS
25GF Score
SELLAS Life Sciences Group Inc SLS
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SELLAS Life Sciences Group OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

SELLAS Life Sciences Group's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-28.389 / 577.19831
=-4.92%

SELLAS Life Sciences Group's annualized OCF Yield % for the quarter that ended in Mar. 2026 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-8.846 * 4 / 767.03859
=-4.61%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -1.56 mean?
SELLAS Life Sciences Group (SLS) has a OCF Yield % of -1.56 as of Jun. 25, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on SELLAS Life Sciences Group and its competitors. According to the industry distribution chart, SELLAS Life Sciences Group ranks #386 out of 1419 companies in the Biotechnology industry, placing it in the top 27.2%.
Is SELLAS Life Sciences Group's OCF Yield % too high?
SELLAS Life Sciences Group's current OCF Yield % is -1.56. Based on the distribution chart, SELLAS Life Sciences Group ranks #386 out of 1419 companies in the Biotechnology industry, which is above the industry midpoint. Overall, SELLAS Life Sciences Group has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does SELLAS Life Sciences Group's OCF Yield % compare to SNDX and CAPR?
According to the Biotechnology industry distribution chart, SELLAS Life Sciences Group ranks #386 out of 1419 companies for OCF Yield %. This puts SELLAS Life Sciences Group in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on SELLAS Life Sciences Group and its competitors. SELLAS Life Sciences Group's current OCF Yield % is -1.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SELLAS Life Sciences Group stock overvalued right now?
SELLAS Life Sciences Group (SLS) has a current OCF Yield % of -1.56. The current OCF Yield % is -1.56. SELLAS Life Sciences Group's overall GF Score™ is 25/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For SELLAS Life Sciences Group (SLS), the current OCF Yield % is -1.56 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

SELLAS Life Sciences Group Business Description

Other Exchanges RXK3:Germany
Address 7 Times Square, Suite 2503, New York, NY, USA, 10036
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
25GF Score

Get the complete analysis for SLS

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.17
Price